Case 1, Answer 4a

Article

Correct! The fact that her glucose concentration remains high PLUS there has been no change in her clinical signs PLUS she is still on a relatively low dose of insulin means her insulin dose needs to be increased.

<< Next step >>

Newsletter

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Subscribe Now!
Recent Videos
Related Content
From stealth to signals: How artificial intelligence is transforming feline medicine

From stealth to signals: How artificial intelligence is transforming feline medicine

Matt McGlasson DVM, CVPM;Kristin Wuhrman
July 7th 2025
Article

When it comes to feline health, listen when silence speaks

Read More

Eye to eye: Navigating ophthalmology emergencies

Eye to eye: Navigating ophthalmology emergencies

Alex Sigmund, DVM, DACVO;Caitlin McCafferty, Editor
March 5th 2025
Podcast

Alex Sigmund, DVM, DACVO, shares his expertise on dealing with ocular emergencies on this episode of The Vet Blast Podcast presented by dvm360.

Listen

Bengal kitten

Developmental and epileptic encephalopathy type 50 is found in a Bengal kitten

Ava Landry, PharmD candidate
June 24th 2025
Article

An investigation highlights the importance of cross-species genetic research and the value of animal models in rare disease studies.

Read More

Updates in treating FIP

Updates in treating FIP

Caitlin McCafferty, Editor
August 28th 2024
Podcast

Drs Adam Christman and Christopher Byers highlight recent FIP treatment advancements

Listen

Study links older age to early mortality and treatment gaps in feline diabetes

Study links older age to early mortality and treatment gaps in feline diabetes

Abi Bautista-Alejandre, Assistant Editor
June 20th 2025
Article

The study, presented at the 2025 ACVIM Forum, found that cats aged greater than or equal to 15 years old were less likely to receive antihyperglycemic therapy.

Read More

British shorthair cat

Novel cardiology therapy for cats is launched

Kristen Coppock Crossley, MA
June 18th 2025
Article

Sirolimus delayed-release tablets (Felycin-CA1; PRN Pharmacal) has conditional approval from the FDA

Read More

© 2025 MJH Life Sciences

All rights reserved.